期刊文献+

氯吡格雷对人脐静脉内皮细胞全基因表达谱的影响及生物信息学分析 被引量:1

Impact of Clopidogrel on Gene Profile of Human Umbilical Vein Endothelial Cell Line and Bioinformatics Analysis
下载PDF
导出
摘要 本研究探讨氯吡格雷对体外培养人脐静脉内皮细胞(EA.hy926)基因表达谱的影响及作用的分子机制。将10μmol/L氯吡格雷与人脐静脉内皮细胞株共培养48 h,运用Affymetrix U133 plus2.0全基因组表达芯片检测氯吡格雷对人脐静脉内皮细胞基因表达谱的影响,应用分子注释系统MAS3.0软件进行聚类分析,实时定量RT-PCR验证基因表达谱结果。结果表明:氯吡格雷作用内皮细胞48 h后,基因芯片分析筛选出差异表达大于1.5倍的基因508个,其中上调基因139个,下调基因369个,包括蛋白结合、转录因子活性、锌离子结合、DNA依赖的转录的调节、转录、RNA剪接等相关基因,RT-PCR验证结果与基因芯片结果一致。结论:氯吡格雷在基因水平通过多条通路调节内皮功能。 This study was purposed to investigate the effect of clopidogrel on gene expression profile of cultrured human umbilical vein endothelial cell(HUVEC) line(EA.hy926),and explore its potential molecule mechanism. A Affymetrix U133 plus 2.0 oligonucleotide microarray was applied to detect the alteration of gene expression profile induced by clopidogrel in HUVEC.Real time RT-PCR was used to verify the result of selected differentially expressing genes.The results showed that total 508 genes(including 139 up-regulated and 369 down-regulated genes) were obtained with differential expression more than 1.5-fold after clopidogrel(10 μmol/L) acted on HUVEC for 48 h.Clopidogrel affec-ted the expression levels of genes involved protein binding,transcription factor activity,zinc ion binding,regulation of DNA-dependent transcription,transcription,RNA splicing and so on.It is concluded that the clopidogrel modulate function of endothelial cells by regulating sets of genes through different paHTHay.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第2期466-472,共7页 Journal of Experimental Hematology
基金 国家科技支撑计划项目(2009BAI86B04)
关键词 氯吡格雷 脐静脉内皮细胞 基因表达谱 生物信息学 clopidogrel umbilical vein endothelial cell gene expression profile bioinformatics
  • 相关文献

参考文献3

二级参考文献32

  • 1Roccaro AM, Hideshima T, Raje N, et al. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. Cancer Res, 2006 ;66 ( 1 ) : 184 - 191.
  • 2Shin DH, Chun YS, Lee DS, et al. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH -mediated repression of hypoxia-inducible factor-1. Blood, 2008 ; 111 (6) : 3131 - 3136.
  • 3Kaluz S, Kaluzowi K, Stanbridge EJ. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1 C-terminal activation domain. Mol Cell Biol, 2006;26(15) :5895 -5907.
  • 4Kallio PJ, Wilson WJ, O' Brien S, et al. Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin- proteasome pathway. J Biol Chem, 1999 ;274 (10) :6519 - 6525.
  • 5Pal S, Claffey KP, Cohen HT, et al. Activation of Sp-1 mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C. J Biol Chem, 1998 ;273 (41) :26277 -26280.
  • 6Mizukami Y, Li J, Zhang X, et al. Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res ,2004 ;64(5 ) :1765 -1772.
  • 7Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood, 2005; 105(4) : 1383 - 1395.
  • 8Hajjar KA, Krishnan S. Annexin Ⅱ: a mediator of the plasmin/ plasminogen activator system. Trends Cardiovasc Med, 1999; 9 (5) : 128 -138.
  • 9Braden AR, Kafka MT, Cunningham L, et al. Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth. J Nanosci Nanotechnol, 2009 ; 9 (5) : 2856 - 2865.
  • 10Bao H, Jiang M, Zhu M, et al. Overexpression of Annexin Ⅱ affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol, 2009; 90(2) : 177 - 185.

共引文献18

同被引文献26

  • 1AGRAWAL A, GANG T B, RUSINOL A E. Recognition func- tions of pentameric C - reactive protein in cardiovascular disease [J]. Mediators Inflamm, 2014, 2014:1 -6.
  • 2MONTECUCCO F, MACH F. New evidences for C - reactive pro- tein (CRP) deposits in the arterial intima as a cardiovascular risk factor[J]. Clin Interv Aging, 2008, 3(2) : 341 -349.
  • 3HADI N R, MOHAMMAD B I, AJEENA I M, et al. Antiathero- sclerotic potential of clopidogrel: antioxidant and anti - inflamma- tory approaches[ J]. Biomed Res Int, 2013, 2013:1 -10.
  • 4TOTANI L, EVANGELISTA V. Platelet -leukocyte interactions in cardiovascular disease and beyond [ J ]. Arterioscler Thromb Vasc Biol, 2010, 30 (12) : 2357 - 2361.
  • 5PALMERINI T, BAROZZI C, TOMASI L, et al. A randomised study comparing the a.ntiplatelet and antinflammatory effect of clo- pidogrel 150 rag/day versus 75 rag/day in patients with ST - seg- ment elevation acute myocardial infarction and poor responsiveness to clopidogreI: results from the DOUBLE study[ J]. Thromb Res, 2010, 125(4) : 309 -314.
  • 6ZHANG B, WU T, CHEN M, et al. The CD40/CD40L system: a new therapeutic target for disease[J]. Immunol Lett, 2013, 153 (1/2) : 58 -61.
  • 7RAMADAN R, DHAWAN S S, SYED H, et al. Effects of clopi- dogrel therapy on oxidative stress, inflammation, vascular func- tion, and progenitor cells in stable coronary artery disease [ J ]. J Cardiovasc Pharmacol, 2014, 63 (4) : 369 - 374.
  • 8YIP H, CHANG L, SUN C, et al. hnpact of clopidogrel on sup- pression of circulating levels of soluble CIM0 ligand in patients with unstable angina undergoing coronary stenting[J]. Am J Car- diol, 2006, 97(2) : 192 -194.
  • 9GE H, ZHOU Y, LIU X, et al. Relationship between plasma in- flammatory markers and platelet aggregation in patients with clopi- dogrel resistance after angioplasty[ J]. Angiology, 2011, 63 ( 1 ) : 62 - 66.
  • 10CERLETTI C, DE GAETANO G, LORENZET R. Platelet - leu- kocyte interactions: multiple links between inflammation, blood coagulation and vascular risk [ J ]. Mediterr J Hematol Infect Dis, 2010, 2(3) : e2010023.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部